Cargando…
The establishment and evaluation of a new model for the prediction of prostate cancer
To develop a new prostate cancer predictor (PCP) model using the combination of total prostate-specific antigen (tPSA), free PSA (fPSA), and complexed PSA (cPSA). The diagnoses of all the included patients were confirmed pathologically in Daping Hospital between December 1, 2011 and December 1, 2014...
Autores principales: | Wang, Qi, Li, Yan-Feng, Jiang, Jun, Zhang, Yong, Liu, Xu-Dong, Li, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369881/ https://www.ncbi.nlm.nih.gov/pubmed/28296726 http://dx.doi.org/10.1097/MD.0000000000006138 |
Ejemplares similares
-
Upregulation of Talin-1 expression associates with advanced pathological features and predicts lymph node metastases and biochemical recurrence of prostate cancer
por: Xu, Ning, et al.
Publicado: (2016) -
Based on biomedical index data: Risk prediction model for prostate cancer
por: Guo, Hanxu, et al.
Publicado: (2021) -
Predictive value of the monocyte-to-lymphocyte ratio in the diagnosis of prostate cancer
por: Xu, Zhanping, et al.
Publicado: (2021) -
Development and validation of a nomogram for predicting prostate cancer in patients with PSA ≤ 20 ng/mL at initial biopsy
por: Wu, Qiang, et al.
Publicado: (2021) -
Value of free/total prostate-specific antigen (f/t PSA) ratios for prostate cancer detection in patients with total serum prostate-specific antigen between 4 and 10 ng/mL: A meta-analysis
por: Huang, Yan, et al.
Publicado: (2018)